Chemical engineers have devised a simpler process for incorporating hydrophobic drugs into tablets or other drug formulations, using nanoemulsions. With this method, it may be possible to make many ...

A large share of medicines developed today may never reach patients for a surprisingly simple reason: they cannot dissolve well enough in water. For most treatments, the oral route remains the gold ...

ANDOVER, Mass.--(BUSINESS WIRE)--Feb 11, 2010 - Today, Formatech, Inc. announced the issuance of U.S. patent 7,659,310, entitled "Methods of Enhancing Solubility of Agents" which covers novel ...

Patients with some cancers, autoimmune diseases, and metabolic disorders often endure time-consuming intravenous (IV) infusions to receive the best protein-based treatments available. Because these ...

New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and ...

The pharmaceutical development of a cardiovascular polypill presents several unique challenges. The selection of the type and number of active drugs to be incorporated requires important consideration ...

The global oral solid dosage pharmaceutical formulation market is on a trajectory of significant expansion, projected to grow from USD 6,29,582.6 million in 2024 to USD 8,95,636.0 million by 2034.

CAMBRIDGE, MA -- About 60 percent of drugs on the market have hydrophobic molecules as their active ingredients. These drugs, which are not soluble in water, can be difficult to formulate into tablets ...